FDMDF (4DMedical) Debt-to-Asset : 0.07 (As of Dec. 2025)


FDMDF 4DMedical Ltd FDMDF
46 GF Score
Price $2.80
GF Value $0.87
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is 4DMedical Debt-to-Asset?

4DMedical FDMDF -6.67% 46 Debt-to-Asset is 0.07 as of Dec. 2025. GuruFocus rates FDMDF with a GF Score™ of 46/100 and a GF Value™ of $0.87 (Significantly Overvalued). The stock has 2 warning signs investors should review.

4DMedical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2025 was $0.76 Mil. 4DMedical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2025 was $6.05 Mil. 4DMedical's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2025 was $92.72 Mil. 4DMedical's debt to asset for the quarter that ended in Dec. 2025 was 0.07.

4DMedical  (OTCPK:FDMDF) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

4DMedical Debt-to-Asset Related Terms

4DMedical Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for 4DMedical's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4DMedical Debt-to-Asset Chart

4DMedical Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Debt-to-Asset
Get a 7-Day Free Trial 0.02 0.08 0.06 0.04 0.05

4DMedical Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.04 0.05 0.05 0.07

FDMDF vs ABT, SYK, MDT: Debt-to-Asset Comparison

For the Medical Devices subindustry, 4DMedical's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

4DMedical Debt-to-Asset vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, 4DMedical's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where 4DMedical's Debt-to-Asset falls into.


FDMDF
46GF Score
4DMedical Ltd FDMDF
Debt-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

4DMedical Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

4DMedical's Debt-to-Asset for the fiscal year that ended in Jun. 2025 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0.71 + 2.094) / 61.727
=0.05

4DMedical's Debt-to-Asset for the quarter that ended in Dec. 2025 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0.76 + 6.047) / 92.724
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.07 mean?
4DMedical (FDMDF) has a Debt-to-Asset of 0.07 as of Dec. 2025. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on 4DMedical and its competitors.
Is 4DMedical's Debt-to-Asset too high?
4DMedical's current Debt-to-Asset is 0.07. Overall, 4DMedical has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 4DMedical's Debt-to-Asset compare to ABT and SYK?
4DMedical's Debt-to-Asset of 0.07 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Medical Devices & Instruments company?
A good Debt-to-Asset depends on the Medical Devices & Instruments industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on 4DMedical and its competitors. 4DMedical's current Debt-to-Asset is 0.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 4DMedical stock overvalued right now?
Based on GuruFocus' analysis, 4DMedical (FDMDF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.87, compared to a current price of $2.80 — trading 221.8% above its estimated fair value. The current Debt-to-Asset is 0.07. 4DMedical's overall GF Score™ is 46/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For 4DMedical (FDMDF), the current Debt-to-Asset is 0.07 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 4DMedical (FDMDF) Overvalued in 2026?

Based on GuruFocus' analysis, 4DMedical stock appears to be overvalued. The current stock price of $2.80 is trading 221.8% above its estimated GF Value™ of $0.87. GuruFocus considers 4DMedical to be Significantly Overvalued.

Key valuation signals for FDMDF:

  • Debt-to-Asset: 0.07
  • GF Value™: $0.87 vs. price of $2.80 (221.8% above fair value)
  • GF Score™: 46/100 with 2 warning signs

No single metric tells the full story. See the FDMDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

4DMedical Business Description

Other Exchanges MQ7:Germany4DX:Australia
Address 700 Swanston Street, Level 7, Melbourne Connect, Carlton, VIC, AUS, 3053
4DMedical Ltd is a company focused on medical research technology and the development of a non-invasive respiratory imaging solution using four-dimensional imaging. The four-dimensional lung imaging technology utilizes mathematical models and algorithms to convert X-ray scans into quantitative data, aiding physicians in managing patients with respiratory and lung diseases.
46GF Score

Get the complete analysis for FDMDF

Debt-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.80
Price
$0.87
GF Value